nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—CYP2B6—malignant glioma	0.714	1	CbGaD
Tramadol—HTR2C—choroid plexus—malignant glioma	0.0192	0.253	CbGeAlD
Tramadol—OPRM1—telencephalic ventricle—malignant glioma	0.00643	0.0844	CbGeAlD
Tramadol—Wound infection—Temozolomide—malignant glioma	0.00573	0.039	CcSEcCtD
Tramadol—HTR2C—telencephalic ventricle—malignant glioma	0.00564	0.074	CbGeAlD
Tramadol—GRIN3A—telencephalon—malignant glioma	0.00321	0.0422	CbGeAlD
Tramadol—Venlafaxine—CYP2B6—malignant glioma	0.00285	0.437	CrCbGaD
Tramadol—Abnormal behaviour—Temozolomide—malignant glioma	0.00253	0.0172	CcSEcCtD
Tramadol—Venlafaxine—SLC6A3—malignant glioma	0.00243	0.372	CrCbGaD
Tramadol—OPRD1—telencephalon—malignant glioma	0.00226	0.0297	CbGeAlD
Tramadol—GRIN3A—central nervous system—malignant glioma	0.00183	0.024	CbGeAlD
Tramadol—OPRM1—brainstem—malignant glioma	0.00174	0.0228	CbGeAlD
Tramadol—Cerebration impaired—Temozolomide—malignant glioma	0.0016	0.0109	CcSEcCtD
Tramadol—Visual acuity reduced—Temozolomide—malignant glioma	0.00158	0.0108	CcSEcCtD
Tramadol—Deep vein thrombosis—Temozolomide—malignant glioma	0.00155	0.0105	CcSEcCtD
Tramadol—OPRM1—telencephalon—malignant glioma	0.00154	0.0203	CbGeAlD
Tramadol—HTR2C—brainstem—malignant glioma	0.00153	0.02	CbGeAlD
Tramadol—Encephalopathy—Carmustine—malignant glioma	0.00152	0.0103	CcSEcCtD
Tramadol—Cyst—Carmustine—malignant glioma	0.00146	0.00991	CcSEcCtD
Tramadol—Tooth disorder—Temozolomide—malignant glioma	0.00145	0.00987	CcSEcCtD
Tramadol—GRIN3A—brain—malignant glioma	0.00145	0.019	CbGeAlD
Tramadol—SLC6A4—brainstem—malignant glioma	0.00145	0.019	CbGeAlD
Tramadol—Hypokinesia—Carmustine—malignant glioma	0.00144	0.00981	CcSEcCtD
Tramadol—Paranoia—Carmustine—malignant glioma	0.00143	0.00972	CcSEcCtD
Tramadol—Burning sensation—Carmustine—malignant glioma	0.0014	0.00954	CcSEcCtD
Tramadol—HTR2C—telencephalon—malignant glioma	0.00135	0.0178	CbGeAlD
Tramadol—Myopathy—Temozolomide—malignant glioma	0.00134	0.00913	CcSEcCtD
Tramadol—Apathy—Temozolomide—malignant glioma	0.00132	0.00896	CcSEcCtD
Tramadol—Flat affect—Temozolomide—malignant glioma	0.00131	0.00888	CcSEcCtD
Tramadol—OPRD1—central nervous system—malignant glioma	0.00129	0.0169	CbGeAlD
Tramadol—SLC6A4—telencephalon—malignant glioma	0.00128	0.0168	CbGeAlD
Tramadol—SLC6A2—brainstem—malignant glioma	0.00127	0.0167	CbGeAlD
Tramadol—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00127	0.00865	CcSEcCtD
Tramadol—Herpes zoster—Temozolomide—malignant glioma	0.00125	0.0085	CcSEcCtD
Tramadol—Dextromethorphan—CYP2B6—malignant glioma	0.00125	0.191	CrCbGaD
Tramadol—OPRK1—central nervous system—malignant glioma	0.00123	0.0162	CbGeAlD
Tramadol—Otitis media—Temozolomide—malignant glioma	0.00121	0.00822	CcSEcCtD
Tramadol—OPRK1—cerebellum—malignant glioma	0.0012	0.0158	CbGeAlD
Tramadol—Hyperaesthesia—Temozolomide—malignant glioma	0.0012	0.00816	CcSEcCtD
Tramadol—Rigors—Temozolomide—malignant glioma	0.00115	0.00784	CcSEcCtD
Tramadol—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00114	0.00778	CcSEcCtD
Tramadol—CHRM3—telencephalon—malignant glioma	0.00114	0.015	CbGeAlD
Tramadol—Endocrine disorder—Temozolomide—malignant glioma	0.00114	0.00772	CcSEcCtD
Tramadol—Speech disorder—Carmustine—malignant glioma	0.00113	0.0077	CcSEcCtD
Tramadol—SLC6A2—telencephalon—malignant glioma	0.00113	0.0148	CbGeAlD
Tramadol—OPRM1—midbrain—malignant glioma	0.00111	0.0145	CbGeAlD
Tramadol—Accidental injury—Carmustine—malignant glioma	0.0011	0.00749	CcSEcCtD
Tramadol—Speech disorder—Temozolomide—malignant glioma	0.00109	0.00744	CcSEcCtD
Tramadol—Disturbance in attention—Temozolomide—malignant glioma	0.00109	0.00739	CcSEcCtD
Tramadol—OPRM1—spinal cord—malignant glioma	0.00108	0.0142	CbGeAlD
Tramadol—Breast pain—Temozolomide—malignant glioma	0.00108	0.00734	CcSEcCtD
Tramadol—Thinking abnormal—Carmustine—malignant glioma	0.00106	0.00724	CcSEcCtD
Tramadol—HTR2C—medulla oblongata—malignant glioma	0.00106	0.014	CbGeAlD
Tramadol—Drug interaction—Carmustine—malignant glioma	0.00105	0.00714	CcSEcCtD
Tramadol—Viral infection—Temozolomide—malignant glioma	0.00104	0.00709	CcSEcCtD
Tramadol—Herpes simplex—Temozolomide—malignant glioma	0.00102	0.00695	CcSEcCtD
Tramadol—OPRD1—brain—malignant glioma	0.00102	0.0134	CbGeAlD
Tramadol—Gait disturbance—Carmustine—malignant glioma	0.000998	0.00679	CcSEcCtD
Tramadol—Hepatic enzyme increased—Temozolomide—malignant glioma	0.000995	0.00677	CcSEcCtD
Tramadol—Coordination abnormal—Carmustine—malignant glioma	0.000992	0.00675	CcSEcCtD
Tramadol—Neck pain—Carmustine—malignant glioma	0.000986	0.00671	CcSEcCtD
Tramadol—OPRK1—brain—malignant glioma	0.000979	0.0128	CbGeAlD
Tramadol—Pulmonary embolism—Carmustine—malignant glioma	0.000974	0.00663	CcSEcCtD
Tramadol—HTR2C—midbrain—malignant glioma	0.000972	0.0128	CbGeAlD
Tramadol—Gait disturbance—Temozolomide—malignant glioma	0.000964	0.00656	CcSEcCtD
Tramadol—Coordination abnormal—Temozolomide—malignant glioma	0.000958	0.00652	CcSEcCtD
Tramadol—HTR2C—spinal cord—malignant glioma	0.000948	0.0125	CbGeAlD
Tramadol—Pulmonary embolism—Temozolomide—malignant glioma	0.000941	0.0064	CcSEcCtD
Tramadol—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.000941	0.0064	CcSEcCtD
Tramadol—Urinary incontinence—Carmustine—malignant glioma	0.00094	0.0064	CcSEcCtD
Tramadol—SLC6A4—midbrain—malignant glioma	0.000922	0.0121	CbGeAlD
Tramadol—Influenza like illness—Temozolomide—malignant glioma	0.000914	0.00622	CcSEcCtD
Tramadol—Urinary incontinence—Temozolomide—malignant glioma	0.000909	0.00618	CcSEcCtD
Tramadol—SLC6A4—spinal cord—malignant glioma	0.000899	0.0118	CbGeAlD
Tramadol—Coma—Carmustine—malignant glioma	0.00089	0.00605	CcSEcCtD
Tramadol—SLC6A2—medulla oblongata—malignant glioma	0.000888	0.0117	CbGeAlD
Tramadol—Neoplasm—Carmustine—malignant glioma	0.000881	0.00599	CcSEcCtD
Tramadol—OPRM1—central nervous system—malignant glioma	0.000877	0.0115	CbGeAlD
Tramadol—Gynaecomastia—Carmustine—malignant glioma	0.000871	0.00593	CcSEcCtD
Tramadol—Dry eye—Temozolomide—malignant glioma	0.000869	0.00591	CcSEcCtD
Tramadol—Neoplasm—Temozolomide—malignant glioma	0.000851	0.00579	CcSEcCtD
Tramadol—Abnormal vision—Carmustine—malignant glioma	0.000849	0.00578	CcSEcCtD
Tramadol—Mental disability—Carmustine—malignant glioma	0.000845	0.00575	CcSEcCtD
Tramadol—Abnormal vision—Temozolomide—malignant glioma	0.000821	0.00558	CcSEcCtD
Tramadol—Phlebitis—Carmustine—malignant glioma	0.000821	0.00558	CcSEcCtD
Tramadol—Mental disability—Temozolomide—malignant glioma	0.000817	0.00556	CcSEcCtD
Tramadol—Diabetes mellitus—Carmustine—malignant glioma	0.000813	0.00553	CcSEcCtD
Tramadol—Ear pain—Temozolomide—malignant glioma	0.000801	0.00545	CcSEcCtD
Tramadol—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.000785	0.00534	CcSEcCtD
Tramadol—Eye pain—Carmustine—malignant glioma	0.000783	0.00533	CcSEcCtD
Tramadol—Gastroenteritis—Temozolomide—malignant glioma	0.000771	0.00524	CcSEcCtD
Tramadol—HTR2C—central nervous system—malignant glioma	0.000769	0.0101	CbGeAlD
Tramadol—Injury—Carmustine—malignant glioma	0.000769	0.00523	CcSEcCtD
Tramadol—Deafness—Temozolomide—malignant glioma	0.000764	0.0052	CcSEcCtD
Tramadol—Vascular purpura—Temozolomide—malignant glioma	0.000764	0.0052	CcSEcCtD
Tramadol—Hepatic failure—Temozolomide—malignant glioma	0.00076	0.00517	CcSEcCtD
Tramadol—Eye pain—Temozolomide—malignant glioma	0.000757	0.00515	CcSEcCtD
Tramadol—Amnesia—Carmustine—malignant glioma	0.000752	0.00512	CcSEcCtD
Tramadol—Nasal congestion—Temozolomide—malignant glioma	0.00075	0.0051	CcSEcCtD
Tramadol—Hot flush—Temozolomide—malignant glioma	0.00073	0.00497	CcSEcCtD
Tramadol—SLC6A4—central nervous system—malignant glioma	0.000729	0.00958	CbGeAlD
Tramadol—Amnesia—Temozolomide—malignant glioma	0.000727	0.00495	CcSEcCtD
Tramadol—Menopausal symptoms—Temozolomide—malignant glioma	0.000724	0.00493	CcSEcCtD
Tramadol—Thirst—Temozolomide—malignant glioma	0.000718	0.00488	CcSEcCtD
Tramadol—Hyponatraemia—Carmustine—malignant glioma	0.00071	0.00483	CcSEcCtD
Tramadol—Purpura—Temozolomide—malignant glioma	0.000709	0.00482	CcSEcCtD
Tramadol—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000707	0.00481	CcSEcCtD
Tramadol—CYP2D6—brainstem—malignant glioma	0.000697	0.00915	CbGeAlD
Tramadol—OPRM1—brain—malignant glioma	0.000696	0.00914	CbGeAlD
Tramadol—Affect lability—Temozolomide—malignant glioma	0.000672	0.00457	CcSEcCtD
Tramadol—Ataxia—Carmustine—malignant glioma	0.000665	0.00452	CcSEcCtD
Tramadol—Liver function test abnormal—Carmustine—malignant glioma	0.000653	0.00444	CcSEcCtD
Tramadol—CHRM3—central nervous system—malignant glioma	0.00065	0.00854	CbGeAlD
Tramadol—Mood swings—Temozolomide—malignant glioma	0.000647	0.0044	CcSEcCtD
Tramadol—Hypokalaemia—Carmustine—malignant glioma	0.000643	0.00438	CcSEcCtD
Tramadol—Ataxia—Temozolomide—malignant glioma	0.000642	0.00437	CcSEcCtD
Tramadol—SLC6A2—central nervous system—malignant glioma	0.000642	0.00843	CbGeAlD
Tramadol—Dehydration—Temozolomide—malignant glioma	0.000635	0.00432	CcSEcCtD
Tramadol—Dry skin—Temozolomide—malignant glioma	0.000626	0.00426	CcSEcCtD
Tramadol—Muscular weakness—Carmustine—malignant glioma	0.000624	0.00424	CcSEcCtD
Tramadol—Hypokalaemia—Temozolomide—malignant glioma	0.000622	0.00423	CcSEcCtD
Tramadol—CYP2D6—telencephalon—malignant glioma	0.000619	0.00812	CbGeAlD
Tramadol—Breast disorder—Temozolomide—malignant glioma	0.000617	0.0042	CcSEcCtD
Tramadol—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000615	0.00418	CcSEcCtD
Tramadol—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.000615	0.00418	CcSEcCtD
Tramadol—Dysphagia—Carmustine—malignant glioma	0.000611	0.00416	CcSEcCtD
Tramadol—HTR2C—brain—malignant glioma	0.000611	0.00802	CbGeAlD
Tramadol—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.000603	0.0041	CcSEcCtD
Tramadol—Muscular weakness—Temozolomide—malignant glioma	0.000603	0.0041	CcSEcCtD
Tramadol—Abdominal distension—Temozolomide—malignant glioma	0.000594	0.00404	CcSEcCtD
Tramadol—Dysphagia—Temozolomide—malignant glioma	0.00059	0.00402	CcSEcCtD
Tramadol—SLC6A4—brain—malignant glioma	0.000579	0.0076	CbGeAlD
Tramadol—Sweating increased—Temozolomide—malignant glioma	0.000575	0.00391	CcSEcCtD
Tramadol—Bronchitis—Temozolomide—malignant glioma	0.000568	0.00386	CcSEcCtD
Tramadol—Dysuria—Temozolomide—malignant glioma	0.000552	0.00376	CcSEcCtD
Tramadol—Hyperglycaemia—Carmustine—malignant glioma	0.000551	0.00375	CcSEcCtD
Tramadol—Upper respiratory tract infection—Temozolomide—malignant glioma	0.000549	0.00373	CcSEcCtD
Tramadol—Pneumonia—Carmustine—malignant glioma	0.000548	0.00373	CcSEcCtD
Tramadol—Pollakiuria—Temozolomide—malignant glioma	0.000545	0.00371	CcSEcCtD
Tramadol—Erectile dysfunction—Temozolomide—malignant glioma	0.000544	0.0037	CcSEcCtD
Tramadol—Depression—Carmustine—malignant glioma	0.000543	0.0037	CcSEcCtD
Tramadol—Photosensitivity reaction—Temozolomide—malignant glioma	0.000539	0.00367	CcSEcCtD
Tramadol—Renal failure—Carmustine—malignant glioma	0.000536	0.00364	CcSEcCtD
Tramadol—Weight decreased—Temozolomide—malignant glioma	0.000534	0.00363	CcSEcCtD
Tramadol—Hyperglycaemia—Temozolomide—malignant glioma	0.000533	0.00362	CcSEcCtD
Tramadol—Stomatitis—Carmustine—malignant glioma	0.000531	0.00361	CcSEcCtD
Tramadol—Urinary tract infection—Carmustine—malignant glioma	0.00053	0.0036	CcSEcCtD
Tramadol—Pneumonia—Temozolomide—malignant glioma	0.00053	0.0036	CcSEcCtD
Tramadol—Infestation NOS—Temozolomide—malignant glioma	0.000526	0.00358	CcSEcCtD
Tramadol—Infestation—Temozolomide—malignant glioma	0.000526	0.00358	CcSEcCtD
Tramadol—Depression—Temozolomide—malignant glioma	0.000525	0.00357	CcSEcCtD
Tramadol—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000522	0.00355	CcSEcCtD
Tramadol—CHRM3—brain—malignant glioma	0.000516	0.00678	CbGeAlD
Tramadol—Stomatitis—Temozolomide—malignant glioma	0.000513	0.00349	CcSEcCtD
Tramadol—Urinary tract infection—Temozolomide—malignant glioma	0.000512	0.00348	CcSEcCtD
Tramadol—SLC6A2—brain—malignant glioma	0.00051	0.00669	CbGeAlD
Tramadol—Hepatobiliary disease—Temozolomide—malignant glioma	0.000498	0.00339	CcSEcCtD
Tramadol—Sinusitis—Temozolomide—malignant glioma	0.000494	0.00336	CcSEcCtD
Tramadol—Haemoglobin—Carmustine—malignant glioma	0.000492	0.00334	CcSEcCtD
Tramadol—Haemorrhage—Carmustine—malignant glioma	0.000489	0.00333	CcSEcCtD
Tramadol—Hallucination—Carmustine—malignant glioma	0.000487	0.00331	CcSEcCtD
Tramadol—Hypoaesthesia—Carmustine—malignant glioma	0.000487	0.00331	CcSEcCtD
Tramadol—Oedema peripheral—Carmustine—malignant glioma	0.000482	0.00328	CcSEcCtD
Tramadol—Connective tissue disorder—Carmustine—malignant glioma	0.000481	0.00327	CcSEcCtD
Tramadol—Haemoglobin—Temozolomide—malignant glioma	0.000475	0.00323	CcSEcCtD
Tramadol—CYP2B6—central nervous system—malignant glioma	0.000473	0.00621	CbGeAlD
Tramadol—Haemorrhage—Temozolomide—malignant glioma	0.000473	0.00322	CcSEcCtD
Tramadol—Hepatitis—Temozolomide—malignant glioma	0.000473	0.00322	CcSEcCtD
Tramadol—Visual impairment—Carmustine—malignant glioma	0.000471	0.00321	CcSEcCtD
Tramadol—Hypoaesthesia—Temozolomide—malignant glioma	0.00047	0.0032	CcSEcCtD
Tramadol—Hallucination—Temozolomide—malignant glioma	0.00047	0.0032	CcSEcCtD
Tramadol—Pharyngitis—Temozolomide—malignant glioma	0.000469	0.00319	CcSEcCtD
Tramadol—Urinary tract disorder—Temozolomide—malignant glioma	0.000467	0.00318	CcSEcCtD
Tramadol—Oedema peripheral—Temozolomide—malignant glioma	0.000466	0.00317	CcSEcCtD
Tramadol—Connective tissue disorder—Temozolomide—malignant glioma	0.000464	0.00316	CcSEcCtD
Tramadol—Urethral disorder—Temozolomide—malignant glioma	0.000463	0.00315	CcSEcCtD
Tramadol—Eye disorder—Carmustine—malignant glioma	0.000457	0.00311	CcSEcCtD
Tramadol—Visual impairment—Temozolomide—malignant glioma	0.000455	0.0031	CcSEcCtD
Tramadol—Flushing—Carmustine—malignant glioma	0.000454	0.00309	CcSEcCtD
Tramadol—Erythema multiforme—Temozolomide—malignant glioma	0.000447	0.00304	CcSEcCtD
Tramadol—Eye disorder—Temozolomide—malignant glioma	0.000442	0.003	CcSEcCtD
Tramadol—Tinnitus—Temozolomide—malignant glioma	0.000441	0.003	CcSEcCtD
Tramadol—Flushing—Temozolomide—malignant glioma	0.000439	0.00298	CcSEcCtD
Tramadol—Cardiac disorder—Temozolomide—malignant glioma	0.000439	0.00298	CcSEcCtD
Tramadol—Arrhythmia—Carmustine—malignant glioma	0.000437	0.00297	CcSEcCtD
Tramadol—Angiopathy—Temozolomide—malignant glioma	0.000429	0.00292	CcSEcCtD
Tramadol—Mental disorder—Carmustine—malignant glioma	0.000428	0.00291	CcSEcCtD
Tramadol—Immune system disorder—Temozolomide—malignant glioma	0.000427	0.0029	CcSEcCtD
Tramadol—Mediastinal disorder—Temozolomide—malignant glioma	0.000426	0.0029	CcSEcCtD
Tramadol—Malnutrition—Carmustine—malignant glioma	0.000426	0.0029	CcSEcCtD
Tramadol—Erythema—Carmustine—malignant glioma	0.000426	0.0029	CcSEcCtD
Tramadol—Chills—Temozolomide—malignant glioma	0.000424	0.00288	CcSEcCtD
Tramadol—Mental disorder—Temozolomide—malignant glioma	0.000414	0.00282	CcSEcCtD
Tramadol—Back pain—Carmustine—malignant glioma	0.000412	0.0028	CcSEcCtD
Tramadol—Erythema—Temozolomide—malignant glioma	0.000411	0.0028	CcSEcCtD
Tramadol—Malnutrition—Temozolomide—malignant glioma	0.000411	0.0028	CcSEcCtD
Tramadol—Dysgeusia—Temozolomide—malignant glioma	0.000403	0.00274	CcSEcCtD
Tramadol—Vision blurred—Carmustine—malignant glioma	0.000401	0.00273	CcSEcCtD
Tramadol—Tremor—Carmustine—malignant glioma	0.000399	0.00271	CcSEcCtD
Tramadol—Back pain—Temozolomide—malignant glioma	0.000398	0.00271	CcSEcCtD
Tramadol—Anaemia—Carmustine—malignant glioma	0.000394	0.00268	CcSEcCtD
Tramadol—Agitation—Carmustine—malignant glioma	0.000391	0.00266	CcSEcCtD
Tramadol—Vision blurred—Temozolomide—malignant glioma	0.000388	0.00264	CcSEcCtD
Tramadol—Tremor—Temozolomide—malignant glioma	0.000385	0.00262	CcSEcCtD
Tramadol—Ill-defined disorder—Temozolomide—malignant glioma	0.000382	0.0026	CcSEcCtD
Tramadol—Anaemia—Temozolomide—malignant glioma	0.00038	0.00259	CcSEcCtD
Tramadol—Agitation—Temozolomide—malignant glioma	0.000378	0.00257	CcSEcCtD
Tramadol—Angioedema—Temozolomide—malignant glioma	0.000376	0.00256	CcSEcCtD
Tramadol—CYP2B6—brain—malignant glioma	0.000376	0.00493	CbGeAlD
Tramadol—Malaise—Temozolomide—malignant glioma	0.000371	0.00252	CcSEcCtD
Tramadol—Vertigo—Temozolomide—malignant glioma	0.00037	0.00251	CcSEcCtD
Tramadol—Convulsion—Carmustine—malignant glioma	0.000369	0.00251	CcSEcCtD
Tramadol—Hypertension—Carmustine—malignant glioma	0.000368	0.0025	CcSEcCtD
Tramadol—Palpitations—Temozolomide—malignant glioma	0.000364	0.00247	CcSEcCtD
Tramadol—Chest pain—Carmustine—malignant glioma	0.000362	0.00247	CcSEcCtD
Tramadol—Myalgia—Carmustine—malignant glioma	0.000362	0.00247	CcSEcCtD
Tramadol—Anxiety—Carmustine—malignant glioma	0.000361	0.00246	CcSEcCtD
Tramadol—Cough—Temozolomide—malignant glioma	0.000359	0.00244	CcSEcCtD
Tramadol—CYP3A4—central nervous system—malignant glioma	0.000357	0.00469	CbGeAlD
Tramadol—Convulsion—Temozolomide—malignant glioma	0.000356	0.00242	CcSEcCtD
Tramadol—Hypertension—Temozolomide—malignant glioma	0.000355	0.00242	CcSEcCtD
Tramadol—CYP2D6—central nervous system—malignant glioma	0.000352	0.00462	CbGeAlD
Tramadol—Confusional state—Carmustine—malignant glioma	0.00035	0.00238	CcSEcCtD
Tramadol—Arthralgia—Temozolomide—malignant glioma	0.00035	0.00238	CcSEcCtD
Tramadol—Myalgia—Temozolomide—malignant glioma	0.00035	0.00238	CcSEcCtD
Tramadol—Anxiety—Temozolomide—malignant glioma	0.000349	0.00237	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000348	0.00237	CcSEcCtD
Tramadol—Discomfort—Temozolomide—malignant glioma	0.000346	0.00235	CcSEcCtD
Tramadol—Infection—Carmustine—malignant glioma	0.000345	0.00235	CcSEcCtD
Tramadol—CYP2D6—cerebellum—malignant glioma	0.000344	0.00451	CbGeAlD
Tramadol—Dry mouth—Temozolomide—malignant glioma	0.000343	0.00233	CcSEcCtD
Tramadol—Thrombocytopenia—Carmustine—malignant glioma	0.00034	0.00231	CcSEcCtD
Tramadol—Tachycardia—Carmustine—malignant glioma	0.000339	0.00231	CcSEcCtD
Tramadol—Confusional state—Temozolomide—malignant glioma	0.000339	0.0023	CcSEcCtD
Tramadol—Anaphylactic shock—Temozolomide—malignant glioma	0.000336	0.00228	CcSEcCtD
Tramadol—Infection—Temozolomide—malignant glioma	0.000334	0.00227	CcSEcCtD
Tramadol—Anorexia—Carmustine—malignant glioma	0.000331	0.00225	CcSEcCtD
Tramadol—Nervous system disorder—Temozolomide—malignant glioma	0.000329	0.00224	CcSEcCtD
Tramadol—Thrombocytopenia—Temozolomide—malignant glioma	0.000329	0.00224	CcSEcCtD
Tramadol—Skin disorder—Temozolomide—malignant glioma	0.000326	0.00222	CcSEcCtD
Tramadol—Hypotension—Carmustine—malignant glioma	0.000325	0.00221	CcSEcCtD
Tramadol—Hyperhidrosis—Temozolomide—malignant glioma	0.000325	0.00221	CcSEcCtD
Tramadol—Anorexia—Temozolomide—malignant glioma	0.00032	0.00218	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000317	0.00215	CcSEcCtD
Tramadol—Insomnia—Carmustine—malignant glioma	0.000314	0.00214	CcSEcCtD
Tramadol—Paraesthesia—Carmustine—malignant glioma	0.000312	0.00212	CcSEcCtD
Tramadol—Dyspnoea—Carmustine—malignant glioma	0.00031	0.00211	CcSEcCtD
Tramadol—Somnolence—Carmustine—malignant glioma	0.000309	0.0021	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000306	0.00208	CcSEcCtD
Tramadol—Insomnia—Temozolomide—malignant glioma	0.000304	0.00207	CcSEcCtD
Tramadol—Decreased appetite—Carmustine—malignant glioma	0.000302	0.00205	CcSEcCtD
Tramadol—Paraesthesia—Temozolomide—malignant glioma	0.000302	0.00205	CcSEcCtD
Tramadol—Gastrointestinal disorder—Carmustine—malignant glioma	0.0003	0.00204	CcSEcCtD
Tramadol—Dyspnoea—Temozolomide—malignant glioma	0.000299	0.00204	CcSEcCtD
Tramadol—Somnolence—Temozolomide—malignant glioma	0.000299	0.00203	CcSEcCtD
Tramadol—Pain—Carmustine—malignant glioma	0.000297	0.00202	CcSEcCtD
Tramadol—Constipation—Carmustine—malignant glioma	0.000297	0.00202	CcSEcCtD
Tramadol—Dyspepsia—Temozolomide—malignant glioma	0.000296	0.00201	CcSEcCtD
Tramadol—Decreased appetite—Temozolomide—malignant glioma	0.000292	0.00199	CcSEcCtD
Tramadol—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00029	0.00197	CcSEcCtD
Tramadol—Fatigue—Temozolomide—malignant glioma	0.00029	0.00197	CcSEcCtD
Tramadol—Pain—Temozolomide—malignant glioma	0.000287	0.00195	CcSEcCtD
Tramadol—Constipation—Temozolomide—malignant glioma	0.000287	0.00195	CcSEcCtD
Tramadol—Feeling abnormal—Carmustine—malignant glioma	0.000286	0.00195	CcSEcCtD
Tramadol—Gastrointestinal pain—Carmustine—malignant glioma	0.000284	0.00193	CcSEcCtD
Tramadol—CYP2D6—brain—malignant glioma	0.000279	0.00366	CbGeAlD
Tramadol—Feeling abnormal—Temozolomide—malignant glioma	0.000277	0.00188	CcSEcCtD
Tramadol—Body temperature increased—Carmustine—malignant glioma	0.000275	0.00187	CcSEcCtD
Tramadol—Abdominal pain—Carmustine—malignant glioma	0.000275	0.00187	CcSEcCtD
Tramadol—Gastrointestinal pain—Temozolomide—malignant glioma	0.000275	0.00187	CcSEcCtD
Tramadol—Urticaria—Temozolomide—malignant glioma	0.000267	0.00181	CcSEcCtD
Tramadol—Body temperature increased—Temozolomide—malignant glioma	0.000265	0.00181	CcSEcCtD
Tramadol—Abdominal pain—Temozolomide—malignant glioma	0.000265	0.00181	CcSEcCtD
Tramadol—Hypersensitivity—Carmustine—malignant glioma	0.000256	0.00174	CcSEcCtD
Tramadol—Asthenia—Carmustine—malignant glioma	0.000249	0.0017	CcSEcCtD
Tramadol—Hypersensitivity—Temozolomide—malignant glioma	0.000247	0.00168	CcSEcCtD
Tramadol—Asthenia—Temozolomide—malignant glioma	0.000241	0.00164	CcSEcCtD
Tramadol—Diarrhoea—Carmustine—malignant glioma	0.000238	0.00162	CcSEcCtD
Tramadol—Pruritus—Temozolomide—malignant glioma	0.000238	0.00162	CcSEcCtD
Tramadol—Dizziness—Carmustine—malignant glioma	0.00023	0.00156	CcSEcCtD
Tramadol—Diarrhoea—Temozolomide—malignant glioma	0.00023	0.00156	CcSEcCtD
Tramadol—Dizziness—Temozolomide—malignant glioma	0.000222	0.00151	CcSEcCtD
Tramadol—Vomiting—Carmustine—malignant glioma	0.000221	0.0015	CcSEcCtD
Tramadol—Rash—Carmustine—malignant glioma	0.000219	0.00149	CcSEcCtD
Tramadol—Dermatitis—Carmustine—malignant glioma	0.000219	0.00149	CcSEcCtD
Tramadol—Headache—Carmustine—malignant glioma	0.000218	0.00148	CcSEcCtD
Tramadol—Vomiting—Temozolomide—malignant glioma	0.000214	0.00145	CcSEcCtD
Tramadol—Rash—Temozolomide—malignant glioma	0.000212	0.00144	CcSEcCtD
Tramadol—Dermatitis—Temozolomide—malignant glioma	0.000212	0.00144	CcSEcCtD
Tramadol—Headache—Temozolomide—malignant glioma	0.00021	0.00143	CcSEcCtD
Tramadol—Nausea—Carmustine—malignant glioma	0.000206	0.0014	CcSEcCtD
Tramadol—Nausea—Temozolomide—malignant glioma	0.000199	0.00136	CcSEcCtD
Tramadol—OPRD1—Signaling Pathways—FGF2—malignant glioma	1.18e-05	0.000209	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HIF1A—malignant glioma	1.18e-05	0.000209	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—IL2—malignant glioma	1.17e-05	0.000207	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GSTT1—malignant glioma	1.16e-05	0.000206	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GSTP1—malignant glioma	1.16e-05	0.000205	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—PIK3CB—malignant glioma	1.16e-05	0.000205	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—BRAF—malignant glioma	1.16e-05	0.000205	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—IDH2—malignant glioma	1.15e-05	0.000204	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PDGFRA—malignant glioma	1.15e-05	0.000204	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PIK3CD—malignant glioma	1.14e-05	0.000203	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CAV1—malignant glioma	1.14e-05	0.000202	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—KDR—malignant glioma	1.13e-05	0.0002	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CAT—malignant glioma	1.13e-05	0.0002	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—AKT2—malignant glioma	1.13e-05	0.000199	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—EGFR—malignant glioma	1.12e-05	0.000198	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SPP1—malignant glioma	1.12e-05	0.000198	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CXCL8—malignant glioma	1.11e-05	0.000197	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—PIK3CA—malignant glioma	1.11e-05	0.000196	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MDM2—malignant glioma	1.1e-05	0.000196	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MMP3—malignant glioma	1.1e-05	0.000195	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—RAF1—malignant glioma	1.1e-05	0.000195	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—PIK3CB—malignant glioma	1.1e-05	0.000194	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CDKN2B—malignant glioma	1.09e-05	0.000193	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—ERBB2—malignant glioma	1.09e-05	0.000193	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PTGS1—malignant glioma	1.09e-05	0.000193	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—FN1—malignant glioma	1.09e-05	0.000192	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—F2—malignant glioma	1.09e-05	0.000192	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.08e-05	0.000192	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PIK3CD—malignant glioma	1.08e-05	0.000191	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PIK3CB—malignant glioma	1.08e-05	0.00019	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—BAD—malignant glioma	1.07e-05	0.00019	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—PIK3CA—malignant glioma	1.07e-05	0.00019	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—NCOR1—malignant glioma	1.07e-05	0.000189	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—IL2—malignant glioma	1.06e-05	0.000188	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NOTCH1—malignant glioma	1.06e-05	0.000188	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PTK2—malignant glioma	1.06e-05	0.000188	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TERT—malignant glioma	1.06e-05	0.000188	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—KRAS—malignant glioma	1.06e-05	0.000187	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CXCL8—malignant glioma	1.06e-05	0.000187	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CD80—malignant glioma	1.04e-05	0.000184	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HES1—malignant glioma	1.04e-05	0.000184	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—APC—malignant glioma	1.04e-05	0.000184	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PIK3CG—malignant glioma	1.04e-05	0.000184	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—FGF2—malignant glioma	1.04e-05	0.000183	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NCOR1—malignant glioma	1.04e-05	0.000183	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PDGFB—malignant glioma	1.03e-05	0.000183	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CXCL8—malignant glioma	1.03e-05	0.000183	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—FGFR1—malignant glioma	1.03e-05	0.000182	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—EGF—malignant glioma	1.03e-05	0.000182	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PTPN11—malignant glioma	1.02e-05	0.000181	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—RAF1—malignant glioma	1.02e-05	0.000181	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HIF1A—malignant glioma	1.01e-05	0.000179	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—BCHE—malignant glioma	1.01e-05	0.000179	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CAV1—malignant glioma	1.01e-05	0.000179	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—IL2—malignant glioma	1.01e-05	0.000179	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—SLC5A5—malignant glioma	1e-05	0.000177	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—AKT1—malignant glioma	9.98e-06	0.000177	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PIK3CB—malignant glioma	9.97e-06	0.000177	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PDGFRA—malignant glioma	9.91e-06	0.000176	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—IDH1—malignant glioma	9.91e-06	0.000175	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CASP3—malignant glioma	9.89e-06	0.000175	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IL2—malignant glioma	9.87e-06	0.000175	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CAV1—malignant glioma	9.8e-06	0.000174	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—BRAF—malignant glioma	9.77e-06	0.000173	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—PIK3CA—malignant glioma	9.73e-06	0.000172	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—KDR—malignant glioma	9.69e-06	0.000172	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MDM2—malignant glioma	9.69e-06	0.000172	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—RAF1—malignant glioma	9.66e-06	0.000171	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SPP1—malignant glioma	9.62e-06	0.00017	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SPHK1—malignant glioma	9.59e-06	0.00017	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CXCL8—malignant glioma	9.58e-06	0.00017	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—ERBB2—malignant glioma	9.55e-06	0.000169	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—AKT2—malignant glioma	9.51e-06	0.000168	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—EGFR—malignant glioma	9.47e-06	0.000168	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PIK3CB—malignant glioma	9.43e-06	0.000167	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP2C18—malignant glioma	9.4e-06	0.000166	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MMP9—malignant glioma	9.34e-06	0.000165	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—FN1—malignant glioma	9.33e-06	0.000165	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—F2—malignant glioma	9.33e-06	0.000165	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PTEN—malignant glioma	9.29e-06	0.000164	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—BAD—malignant glioma	9.22e-06	0.000163	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CG—malignant glioma	9.19e-06	0.000163	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL2—malignant glioma	9.16e-06	0.000162	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PIK3CD—malignant glioma	9.14e-06	0.000162	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NOTCH1—malignant glioma	9.13e-06	0.000162	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TERT—malignant glioma	9.12e-06	0.000162	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—AKT1—malignant glioma	9.06e-06	0.00016	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CXCL8—malignant glioma	9.06e-06	0.00016	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—PIK3CA—malignant glioma	9.05e-06	0.00016	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—KRAS—malignant glioma	8.95e-06	0.000158	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CD80—malignant glioma	8.94e-06	0.000158	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CG—malignant glioma	8.93e-06	0.000158	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—APC—malignant glioma	8.93e-06	0.000158	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PDGFB—malignant glioma	8.91e-06	0.000158	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PPARG—malignant glioma	8.87e-06	0.000157	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—FGFR1—malignant glioma	8.86e-06	0.000157	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—EGF—malignant glioma	8.83e-06	0.000156	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PTPN11—malignant glioma	8.77e-06	0.000155	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—FGF2—malignant glioma	8.75e-06	0.000155	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—AKT1—malignant glioma	8.75e-06	0.000155	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HIF1A—malignant glioma	8.73e-06	0.000154	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CAV1—malignant glioma	8.68e-06	0.000154	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CASP3—malignant glioma	8.67e-06	0.000154	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL2—malignant glioma	8.66e-06	0.000153	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CAV1—malignant glioma	8.44e-06	0.000149	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—BRAF—malignant glioma	8.39e-06	0.000149	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—VEGFA—malignant glioma	8.39e-06	0.000149	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KDR—malignant glioma	8.34e-06	0.000148	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—STAT3—malignant glioma	8.31e-06	0.000147	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—PIK3CA—malignant glioma	8.22e-06	0.000146	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MMP9—malignant glioma	8.19e-06	0.000145	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MDM2—malignant glioma	8.19e-06	0.000145	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—AKT2—malignant glioma	8.17e-06	0.000145	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—RAF1—malignant glioma	8.16e-06	0.000144	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PTEN—malignant glioma	8.15e-06	0.000144	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—EGFR—malignant glioma	8.13e-06	0.000144	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CD—malignant glioma	8.08e-06	0.000143	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—ERBB2—malignant glioma	8.07e-06	0.000143	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GSTP1—malignant glioma	8.06e-06	0.000143	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—FN1—malignant glioma	8.03e-06	0.000142	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—F2—malignant glioma	8.03e-06	0.000142	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PIK3CB—malignant glioma	7.97e-06	0.000141	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—AKT1—malignant glioma	7.95e-06	0.000141	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—BAD—malignant glioma	7.94e-06	0.000141	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CG—malignant glioma	7.91e-06	0.00014	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NOTCH1—malignant glioma	7.86e-06	0.000139	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CD—malignant glioma	7.85e-06	0.000139	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CAT—malignant glioma	7.84e-06	0.000139	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—PIK3CA—malignant glioma	7.77e-06	0.000138	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MYC—malignant glioma	7.72e-06	0.000137	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CD80—malignant glioma	7.7e-06	0.000136	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—APC—malignant glioma	7.69e-06	0.000136	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CG—malignant glioma	7.69e-06	0.000136	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—KRAS—malignant glioma	7.68e-06	0.000136	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CXCL8—malignant glioma	7.66e-06	0.000136	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PPARG—malignant glioma	7.63e-06	0.000135	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTT1—malignant glioma	7.6e-06	0.000135	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EGF—malignant glioma	7.6e-06	0.000135	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PTPN11—malignant glioma	7.55e-06	0.000134	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—EGFR—malignant glioma	7.55e-06	0.000134	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—FGF2—malignant glioma	7.52e-06	0.000133	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—NCOR1—malignant glioma	7.4e-06	0.000131	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—AKT1—malignant glioma	7.4e-06	0.000131	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—VEGFA—malignant glioma	7.36e-06	0.00013	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CASP3—malignant glioma	7.33e-06	0.00013	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL2—malignant glioma	7.32e-06	0.00013	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—STAT3—malignant glioma	7.29e-06	0.000129	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—BRAF—malignant glioma	7.23e-06	0.000128	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—KRAS—malignant glioma	7.13e-06	0.000126	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PTGS1—malignant glioma	7.12e-06	0.000126	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—PIK3CA—malignant glioma	7.06e-06	0.000125	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CB—malignant glioma	7.04e-06	0.000125	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AKT2—malignant glioma	7.03e-06	0.000125	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MDM2—malignant glioma	7.03e-06	0.000125	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—RAF1—malignant glioma	7.01e-06	0.000124	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—EGFR—malignant glioma	7e-06	0.000124	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PTGS2—malignant glioma	6.98e-06	0.000124	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CD—malignant glioma	6.95e-06	0.000123	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—ERBB2—malignant glioma	6.93e-06	0.000123	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MMP9—malignant glioma	6.92e-06	0.000123	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PTEN—malignant glioma	6.88e-06	0.000122	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CB—malignant glioma	6.84e-06	0.000121	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MYC—malignant glioma	6.77e-06	0.00012	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CD—malignant glioma	6.76e-06	0.00012	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—AKT1—malignant glioma	6.72e-06	0.000119	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—PIK3CA—malignant glioma	6.69e-06	0.000119	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—EGFR—malignant glioma	6.62e-06	0.000117	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—BCHE—malignant glioma	6.62e-06	0.000117	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—KRAS—malignant glioma	6.62e-06	0.000117	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CXCL8—malignant glioma	6.57e-06	0.000116	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PIK3CA—malignant glioma	6.55e-06	0.000116	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SLC5A5—malignant glioma	6.54e-06	0.000116	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—FGF2—malignant glioma	6.47e-06	0.000115	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—AKT1—malignant glioma	6.35e-06	0.000112	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TP53—malignant glioma	6.34e-06	0.000112	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CASP3—malignant glioma	6.29e-06	0.000111	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL2—malignant glioma	6.28e-06	0.000111	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—KRAS—malignant glioma	6.25e-06	0.000111	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—VEGFA—malignant glioma	6.22e-06	0.00011	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—STAT3—malignant glioma	6.16e-06	0.000109	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PTEN—malignant glioma	6.09e-06	0.000108	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PIK3CA—malignant glioma	6.08e-06	0.000108	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CB—malignant glioma	6.06e-06	0.000107	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MDM2—malignant glioma	6.05e-06	0.000107	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CAV1—malignant glioma	6.03e-06	0.000107	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—RAF1—malignant glioma	6.03e-06	0.000107	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PTGS2—malignant glioma	6e-06	0.000106	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ERBB2—malignant glioma	5.97e-06	0.000106	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MMP9—malignant glioma	5.95e-06	0.000105	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PTEN—malignant glioma	5.91e-06	0.000105	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CB—malignant glioma	5.89e-06	0.000104	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—AKT1—malignant glioma	5.77e-06	0.000102	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PIK3CA—malignant glioma	5.75e-06	0.000102	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MYC—malignant glioma	5.72e-06	0.000101	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CXCL8—malignant glioma	5.66e-06	0.0001	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—EGFR—malignant glioma	5.6e-06	9.91e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TP53—malignant glioma	5.56e-06	9.84e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CG—malignant glioma	5.5e-06	9.73e-05	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—AKT1—malignant glioma	5.47e-06	9.68e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CASP3—malignant glioma	5.42e-06	9.59e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL2—malignant glioma	5.41e-06	9.58e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—AKT1—malignant glioma	5.35e-06	9.48e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—VEGFA—malignant glioma	5.34e-06	9.45e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PPARG—malignant glioma	5.31e-06	9.39e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—STAT3—malignant glioma	5.29e-06	9.36e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—KRAS—malignant glioma	5.29e-06	9.36e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTP1—malignant glioma	5.27e-06	9.33e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PTEN—malignant glioma	5.24e-06	9.27e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CAT—malignant glioma	5.13e-06	9.07e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MMP9—malignant glioma	5.12e-06	9.07e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PTEN—malignant glioma	5.09e-06	9.01e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—AKT1—malignant glioma	4.97e-06	8.79e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MYC—malignant glioma	4.91e-06	8.7e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PIK3CA—malignant glioma	4.86e-06	8.6e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NCOR1—malignant glioma	4.84e-06	8.57e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CD—malignant glioma	4.83e-06	8.56e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—EGFR—malignant glioma	4.81e-06	8.51e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TP53—malignant glioma	4.7e-06	8.32e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—AKT1—malignant glioma	4.69e-06	8.31e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—VEGFA—malignant glioma	4.6e-06	8.14e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—STAT3—malignant glioma	4.55e-06	8.06e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—KRAS—malignant glioma	4.54e-06	8.04e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CA—malignant glioma	4.29e-06	7.6e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MYC—malignant glioma	4.23e-06	7.49e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CB—malignant glioma	4.21e-06	7.46e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PTGS2—malignant glioma	4.17e-06	7.39e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	4.17e-06	7.38e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EGFR—malignant glioma	4.14e-06	7.33e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TP53—malignant glioma	4.03e-06	7.14e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—AKT1—malignant glioma	3.97e-06	7.02e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CAV1—malignant glioma	3.95e-06	6.99e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KRAS—malignant glioma	3.91e-06	6.92e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CA—malignant glioma	3.69e-06	6.54e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PTEN—malignant glioma	3.64e-06	6.44e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.59e-06	6.36e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CA—malignant glioma	3.59e-06	6.36e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—AKT1—malignant glioma	3.51e-06	6.21e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TP53—malignant glioma	3.47e-06	6.15e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PPARG—malignant glioma	3.47e-06	6.14e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—AKT1—malignant glioma	3.41e-06	6.03e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.16e-06	5.59e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—AKT1—malignant glioma	3.02e-06	5.34e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AKT1—malignant glioma	2.93e-06	5.19e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.75e-06	4.88e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PTGS2—malignant glioma	2.73e-06	4.83e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.57e-06	4.55e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PTEN—malignant glioma	2.38e-06	4.21e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—AKT1—malignant glioma	2.1e-06	3.71e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.68e-06	2.97e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—AKT1—malignant glioma	1.37e-06	2.43e-05	CbGpPWpGaD
